| Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase … R Invernizzi, F Quaglia, C Klersy, F Pagella, F Ornati, F Chu, E Matti, ... The Lancet Haematology 2 (11), e465-e473, 2015 | 70 | 2015 |
| Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) identifies a new Sp1 binding-site S Plumitallo, L Ruiz-Llorente, C Langa, J Morini, G Babini, D Cappelletti, ... Gene 647, 85-92, 2018 | 10 | 2018 |
| Characterization of a mutation in the zona pellucida module of Endoglin that causes hereditary hemorrhagic telangiectasia L Ruiz-Llorente, E Chiapparino, S Plumitallo, C Danesino, ... Gene, 2019 | 5 | 2019 |
| Different forms of pulmonary hypertension in a family with clinical and genetic evidence for hereditary hemorrhagic teleangectasia type 2 A Greco, S Plumitallo, L Scelsi, G Maggi, M Sobrero, A Turco, C Raineri, ... Pulmonary circulation 8 (4), 2045894018782664, 2018 | 4 | 2018 |
| ACVRL1 (activin A receptor type II-like 1) F Ornati, L Vecchia, C Scotti, S Plumitallo, C Olivieri Atlas of Genetics and Cytogenetics in Oncology and Haematology, 2014 | 2 | 2014 |
| Circulating microRNAs in hereditary hemorrhagic telangiectasia: preliminary results identify significant differences among patients S Plumitallo, M Grasso, F Pagella, G Babini, G Spinozzi, J Morini, ... ANGIOGENESIS 21 (1), 154-154, 2018 | | 2018 |
| Functional analysis of a novel ENG variant in a patient with hereditary hemorrhagic telangiectasia (HHT) and pulmonary arterial hypertension (PAH) identifies a new SP1 binding site S Plumitallo, L Ruiz-Llorente, C Langa, J Morini, G Babini, D Cappelletti, ... ANGIOGENESIS 21 (1), 150-150, 2018 | | 2018 |
| Genetic characteristics of the HHT Italian population: the experience of the three Italian Reference Centres S Plumitallo, GM Lenato, P Suppressa, E Matti, G Manfredi, S Alicante, ... ANGIOGENESIS 21 (1), 150-150, 2018 | | 2018 |
